(Q36405647)

14 August 2017

1 reference

title

Disorders of glucose metabolism in the context of human immunodeficiency virus infection (English)

1 reference

14 August 2017

0 references

Ruth Larson

1

1 reference

14 August 2017

Bernadette Capili

2

1 reference

14 August 2017

Margaret Eckert-Norton

3

1 reference

14 August 2017

Joseph P Colagreco

4

1 reference

14 August 2017

Joyce K Anastasi

5

1 reference

14 August 2017

1 March 2006

1 reference

Journal of the American Academy of Nurse Practitioners

14 August 2017

1 reference

14 August 2017

18

1 reference

14 August 2017

3

1 reference

14 August 2017

92-103

1 reference

Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Minimal change nephropathy and graves' disease: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

HIV infection, highly active antiretroviral therapy and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Alanine aminotransferase levels predict insulin resistance in HIV lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Inflammation: the link between insulin resistance, obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Disorders of glucose metabolism in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Type 2 diabetes: treat to target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Acquired and inherited lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Insulin and carbohydrate dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Interventions for metabolic and endocrine complications of human immunodeficiency virus/acquired immune deficiency syndrome and illicit drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Adiponectin and HIV-lipodystrophy: taking HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Oral therapies for diabetic hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Insulin resistance and its treatment by thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Treatment of insulin resistance in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Insulin resistance in HIV-infected patients: relationship with pro-inflammatory cytokines released by peripheral leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Metabolic complications associated with HIV protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

HIV, HAART, and hyperlipidemia: balancing the effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2006.00109.X

10.1111/J.1745-7599.2006.00109.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference